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Abstract
Background: Until the 1970s the prevalence of non-venereal trepanomatosis, including yaws, was greatly reduced after
worldwide mass treatment. In 2005, cases were again reported in the Democratic Republic of the Congo. We carried out a
survey to estimate the village-level prevalence of yaws in the region of Equator in the north of the country in order to define
appropriate strategies to effectively treat the affected population.
Methodology/Principal Findings: We designed a community-based survey using the Lot Quality Assurance Sampling
method to classify the prevalence of active yaws in 14 groups of villages (lots). The classification into high, moderate, or low
yaws prevalence corresponded to World Health Organization prevalence thresholds for identifying appropriate operational
treatment strategies. Active yaws cases were defined by suggestive clinical signs and positive rapid plasma reagin and
Treponema pallidum hemagglutination serological tests. The overall prevalence in the study area was 4.7% (95% confidence
interval: 3.4–6.0). Two of 14 lots had high prevalence (.10%), three moderate prevalence (5–10%) and nine low prevalence
(,5%.).
Conclusions/Significance: Although yaws is no longer a World Health Organization priority disease, the presence of yaws in
a region where it was supposed to be eradicated demonstrates the importance of continued surveillance and control
efforts. Yaws should remain a public health priority in countries where previously it was known to be endemic. The
integration of sensitive surveillance systems together with free access to effective treatment is recommended. As a
consequence of our study results, more than 16,000 people received free treatment against yaws.
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Introduction
Yaws is a communicable, non-venereal treponematosis caused by
the bacteria Treponema pallidum subsp. pertenue. There are two other types
of non-venereal endemic treponematosis: endemic syphilis (caused by
Treponema pallidum subsp. endemicum) ,w h i c hi sm a i n l yo b s e r v e di ns o m e
drier parts of Africa and Asia and may be transmitted by shared use of
eating and drinking utensils as well as by skin-to-skin contact, and pinta
(caused by Treponema carateum), which exists only in parts of Latin
America. The three non-venereal endemic treponematoses diseases
and venereal syphilis (caused by Treponema pallidum subsp. pallidum)c a n
only be distinguished by epidemiological characteristics and clinical
manifestations, as the commonly used serological tests can not
discriminate one disease from the others. Yaws is the most widespread
non-venereal treponematosis and is known to be endemic in the
Equator province of Democratic Republic of the Congo (DRC) [1].
The disease is transmitted from person to person by direct skin-to-skin
contact. It predominantly affects children under 15 years of age in the
most underprivileged, remote rural communities. Favourable climate
conditions such as humidity and a constant warm temperature appear
to be especially important factors for yaws to flourish [2–4].
The evolution of yaws is revealed in three stages of clinical
manifestations [2]. Early yaws encompasses both the primary and
secondary stages (active yaws cases). During the primary stage (3–4
weeks incubation), patients display papillomatous raspberry-like
lesions located mainly on the feet and legs. They also have
ulcerations of variable size on other sites of the body that are
highly contagious. Patients may spontaneously recover from the
primary stage or progress to the second stage. The secondary stage
consists of several episodes, lasting three to six months, of both
contagious and non-contagious lesions. These primary and
secondary stages usually last up to five years from the time of
infection, with periods of latency in between symptomatic episodes
[3]. About 10% of patients with untreated secondary stages pass
into the tertiary stage (late yaws), which can occur up to 15 years
after the secondary stage [5]. Late lesions may involve the skin and
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destruction is common and characteristic. Third stage lesions are
not contagious but disable people in their daily activities [2,3,6].
There is evidence that potential sequelae of latent yaws include
congenital, visceral, and tertiary central nervous system lesions and
may lead to significant osseous, neurological, and ophthalmologic
complications [7,8]. Since the 1940s, a single intramuscular
injection of long acting benzathine penicillin has been successfully
used for treatment [1,9].
In the early 1950s an estimated 50 to 100 million people were
infected in tropical areas particularly in Africa, Southeast Asia and
South America [5]. Following a decision of the Second World
Health Assembly in 1949, huge mass treatment campaigns against
endemic treponematosis were undertaken in all affected countries
with the support of the World Health Organization (WHO). The
goal was to eradicate this disease. More than 50 million cases and
their direct contacts were treated and, as a result, the prevalence of
yaws decreased dramatically to an estimated one to two million
cases in the 1980s [10]. Since then, yaws has not been considered a
health priority and it is no longer a reportable disease.
However, difficulties encountered by many countries in
integrating continued control measures into local health services
have led to a gradual build-up and extension of the treponemal
reservoir. Thus, after enthusiastic mass treatment campaigns to
eradicate yaws until mid-1960s, there has been a strong
recrudescence of this disease in the last decades [11–13]. Today
the situation is particularly precarious in the Sahelian region and
western and central Africa where untreated reservoirs of infection
are increasing [14–16]. The distribution of yaws is closely related
to poverty and isolation from organized social and health services,
particularly in rural tropical areas [3].
In DRC yaws was thought to be eradicated in the early 1960s.
However, in 1975, a study revealed yaws cases among the pygmies
in the north of DRC, one of the socio-economically most
disadvantaged populations, with up to 90% of the population
showing serological evidence of infection at that time [17].
Furthermore, in 1981 endemic foci of yaws with a prevalence of
8% were also identified in the north of DRC [18]. Between 1983
and 1988 almost 2500 yaws cases were reported to WHO [19].
In early 2005, an increased number of yaws cases confirmed
through clinical screening were reported from the rural Wasolo
health zone, a very remote and isolated region in the north of DRC
Equator province (Figure 1). The Ministry of Health and local
authorities asked Me ´decins sans Frontie `res (MSF) to investigate the
yaws prevalence and to identify appropriate treatment strategies.
Currently, three different treatment strategies are recommended by
WHO according to the observed prevalence of the disease in
affected populations: (1) total mass treatment for high prevalence
(hyperendemic, over 10%); (2) treatment of active cases, their direct
contacts and all children under 15 years (juvenile mass treatment)
for medium prevalence (mesoendemic, between 5 and 10%); and (3)
treatment of both active cases and direct contacts (selective mass
treatment) for low prevalence (hypoendemic, under 5%) areas [2].
MSF and Epicentre conducted a study to estimate the village-level
prevalence in the population of the rural Wasolo health zone using Lot
Quality Assurance Sampling (LQAS) [20] with the aim of treating the
affected population appropriately. The overall prevalence of active
yaws in the rural health zone was also estimated.
Methods
Study design, setting and population
Between February 16 and March 1, 2005, we carried out a
community-based survey in the rural Wasolo health zone, Equator
province (Figure 1), after approval from the Ministry of Health in
DRC. The population of approximately 32,000 inhabitants [21]
lived in 35 villages all situated close to the only road in the area.
All persons older than 6 months living in the 35 villages on the first
day of the survey were eligible for inclusion. Children under 6 months
of age were excluded for ethical reasons (e.g. taking blood samples
under basic field conditions). Written, informed consent was obtained
from all participants or his/her legal guardian before inclusion.
Prevalence of active yaws cases
We used the LQAS method to classify the prevalence of active
yaws in groups of villages (lots). The LQAS method has been
shown to be useful in identifying areas with high prevalence of
disease [22–26]. We used two LQAS sampling plans to classify
prevalence into three categories [24–26]: n1=84, d1=7 and
n2=84, d2=3. The prevalence in each lot was classified as follows:
d.7 classify prevalence as ‘‘high’’
d between 4 and 7 classify prevalence as ‘‘moderate’’
d between 0 and 3 classify prevalence as ‘‘low’’
where d corresponds to the number of active yaws cases found in
the lot sample. The classifications of ‘‘high’’, ‘‘moderate’’, and
‘‘low’’ correspond to the WHO prevalence thresholds for
identifying appropriate public health interventions and operational
treatment strategies [2].
To ensure lotshad similar population sizes, we grouped between one
to five villages together according to their geographical proximity,
naturalboundariessuchasriversorfieldsandpopulationsize(Figure2).
Villages with a small population were more likely to be grouped
together than larger villages. We defined a total of 14 lots.
We developed a systematic sampling scheme to randomly select
84 households (defined as a group of people living together and
eating from the same pot) from each lot. The size of the sample
taken from each village was weighted by the village population so
that larger villages contributed more to the lot sample than smaller
villages. A uniform sampling fraction was used. The overall lot
sample was, therefore, a proportionate, stratified sample [26,27].
A complete sample (n=84) was taken from each lot.
As yaws is known to cluster in households, we decided to select
only one person per household for participation in the study. This
simplified sampling because it allowed households, rather than
individuals, to be sampled. This approach has been validated
previously in LQAS surveys of trachoma prevalence [24].
All of the villages in the survey area consisted of a single ribbon of
houses situated along a road. This made it possible to use a
straightforward systematic sampling method to select households.
The number of households in the village was estimated by counting
doors. A sampling interval was calculated as the ratioof the estimated
number of households to the required sample size in the village.
One end of the village was selected by tossing a coin. A random
number between one and the sampling interval (inclusive) was
read from a table of random numbers. Study teams walked
towards the opposite end of the village, counting the houses that
they passed, sampling the house indicated by the random number.
Subsequent houses were sampled by repeated application of the
sampling interval. Sampling stopped when the surveyors reached
the calculated number of households for that village.
When a house was sampled, household members were listed
and assigned a sequential number. One household member was
then sampled at random using a random number table.
The day before study teams arrived in the villages, we visited the
chief of the village to seek his permission to survey and to sensitise
the population to be present on the day of the study. In the very
few cases that households were empty and household members
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nearest household was sampled.
Study procedure
For the detection of yaws lesions, the study population was
examined following a standardized checklist for clinical signs
suggestive of yaws. Primary yaws chancre was defined as chronic
non-genital, painless, non-tender papule (mother yaw), which
bursts open and may present as a traumatic ulcer with raised
margin located on the legs, feet or buttocks. Secondary lesions,
which might be concomitant to the primary lesion, included
painful raspberry-like cutaneous lesions (papilloma and papules) in
various numbers eventually affecting palms or soles, and painful
tender osteoperiostitis affecting the fingers (polydactilitis), nose
(‘‘goundou’’), tibia or forearm. Tertiary late lesions were defined as
mutilating facial ulcer around the nose (‘‘gangosa’’), skin
gummata, hyperkeratosis of the palms or soles, juxta-articular
nodules, or bone deformity including sabre shin tibia. Four teams
of three persons each (medical officer, nurse and assistant) carried
out the field investigation under the supervision of both an
epidemiologist and a dermatologist. Each team took between three
and four days to finish one lot. Prior to initiating the survey, the
teams received two days of on-site training with special focus on
the clinical diagnosis using illustrative pictures and including half a
day to pilot the questionnaire.
In the case of clinical suspicion of yaws, individuals or their
caretakers/parents if the individual was younger than 15 years
were asked about the duration of the lesions and a blood sample
(5 ml) was collected for rapid plasma reagin (RPR) and Treponema
pallidum hemagglutination (TPHA) tests. Immediate treatment with
intramuscular long-acting penicillin was given according to WHO
recommendations. To reduce pain of intramuscular injections,
diluted Lidocaine hydrochloride 1% (1/4) was systematically
added to the treatment [28].
Blood samples were centrifuged and stored at 2–8uC. Using a
cold chain they were sent to the MSF laboratory in Botetenza
(DRC) where an MSF laboratory technician performed all RPR
(non-treponemal antigen, RPR-nosticonH II, Biome ´rieux, Hol-
land) tests. For all RPR positive blood samples, a TPHA
(treponemal antigen, Syphilis TPHA liquidH, Human, Germany)
test was performed afterwards.
Case ascertainment
Participants were defined as having active yaws if they presented
with cutaneous lesions clinically suggestive of yaws and scored positive
on both the non-specific RPR test and the specific TPHA test.
Figure 1. Map of the rural Wasolo health zone, Equator province, Democratic Republic of the Congo, February 2005.
doi:10.1371/journal.pone.0006338.g001
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Data were entered into the database using Epi-Data 3.0 software
(The EpiData Association, Odense, Denmark). Double data entry and
cleaning were performed to check for inconsistencies and errors were
corrected. The analysis was done using Stata 8.0 (Stata Corporation,
College Station; Texas, USA). In order to calculate the overall
prevalence of yaws in the study population, the number of cases in the
different lots was weighted according to each lot’s population size and
combined. Symmetric confidence intervals (95%CI) were calculated
after weighting according to each lot’s population size. All data
presented take into account weighting if required.
Results
None of the selected households refused to participate in the
study. Demographic characteristics of the study population
(n=1176) are shown in Table 1.
Prevalence of active yaws in the identified lots
Two of 14 lots presented more than seven confirmed active yaws
cases, indicating a high prevalence of over 10%. In these lots, total
mass treatment was the chosen treatment strategy. For three lots,
the number of confirmed active yaws cases was between four and
seven (inclusive), indicating a moderate prevalence of 5–10%. Here,
juvenile mass treatment was chosen as the treatment strategy. For
the remaining nine lots, the number of confirmed active yaws cases
was three or lower, indicating a low prevalence of below 5%.
Selective mass treatment was chosen as the treatment strategy
(Table 2). Figure 2 shows the geographical distribution of all
investigated lots with their corresponding prevalence of active yaws.
Overall prevalence of active yaws in the study population
Among 1176 persons examined, 383 (32.6%) presented with
cutaneous lesions clinically suggestive of yaws and were tested by
RPR. Of these, 223 (58.2%) were RPR positive. Out of the 223
RPR positive individuals, 56 (25.1%) were TPHA positive and
defined as having truly active yaws. The overall prevalence of
active yaws in the rural Wasolo health zone was 4.7% (95%CI:
3.4–6.0, 56/1176). When separated in two age groups, the overall
prevalence of active yaws was 6.1% (95%CI: 3.4–8.9, 22/395) for
persons less than 15 years of age and 4.0% (95%CI: 2.6–5.5, 33/
765) for those being 15 years and older (age data missing for 16
study participants in the denominator and one case in the
numerator).
Figure 2. Geographical distributions of active yaw cases per lot and classification of yaws prevalence, rural Wasolo health zone,
Equator province, Democratic Republic of the Congo, February 2005.
doi:10.1371/journal.pone.0006338.g002
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with active yaws confirmed by RPR and TPHA testing, rural Wasolo health zone, Equator province, Democratic Republic of the
Congo, February 2005.
Study population
Persons with cutaneous lesions
clinically suggestive of yaws
Persons with active yaws confirmed by
RPR* and TPHA
{ testing
N=1176 N=383 N=55
{
Median age in years (IQR
#) 23 (9–45) 22 (8–45) 21 (10–55)
Range (Minimum, Maximum) 1, 80 7, 72 2, 72
,5 (%) 146 (12.4) 50 (13.1) 3 (5.6)
5–14 (%) 249 (21.2) 94 (24.5) 19 (34.5)
15–29 (%) 287 (24.4) 86 (22.5) 7 (12.7)
30–45 (%) 186 (15.8) 54 (14.1) 7 (12.7)
$45 (%) 292 (24.8) 99 (25.8) 19 (34.5)
Unknown (%) 16 (1.4) –
Sex ratio (male/female) 1.2 (643/526)
1 1.6 (236/146)
6 1.8 (35/20)
Median household size [IQR
#] 7 [5–9] 7 [5–9] 7 [5–9]
Main household activity
Farming (%) 852 (72.4) 281 (73.4) 42 (76.4)
*Rapid Plasma Reagin test.
{Treponema pallidum hemagglutination test.
{1 missing data for all listed variables.
#Inter-quartile range.
17 missing data for sex.
61 missing data for sex.
doi:10.1371/journal.pone.0006338.t001
Table 2. Distribution of active yaw cases per lot and classification of yaws prevalence, rural Wasolo health zone, Equator province,
Democratic Republic of the Congo, February 2005.
Study lot Village name number Number of active yaws cases Prevalence Treatment strategy used
1
suspected confirmed
clinically
* + RPR
{ + RPR + TPHA
{
1 Vadale, Lima, Vato 15 7 3 low SMT
2 Toli, Lunza, Vangbandi, Tongunde 18 7 1 low SMT
3 Liboko, PEFA I+II, Bige, Ndesogo 22 13 2 low SMT
4 Ngaba, Soli 15 10 0 low SMT
5 Tiri, Tari Bondi, Ndanu 39 21 3 low SMT
6 Torunga, Konzi, Ngbongbo Kondia 33 25 4 medium JMT
7 Ngbongbo Vatiri, Ngbongbo Sida, Ngbongbo
Tongonze
36 18 11 high TMT
8 Ngbongbo Tokonzi, Mando 36 26 15 high TMT
9 Modale I 24 11 4 medium JMT
10 Modale II, Nzinga 20 6 1 low SMT
11 Bige, Lupu, Ngwado 42 28 6 medium JMT
12 Ndangba, Kuzangu 14 9 3 low SMT
13 Vamburu - Beta/Koto 33 25 1 low SMT
14 Wasolo mission 36 17 2 low SMT
TOTAL 383 223 56
*Diagnosed clinically.
{Rapid Plasma Reagin test.
{Treponema pallidum hemagglutination test.
1TMT (total mass treatment); JMT (juvenile mass treatment, treatment of active cases, their direct contacts and all children under 15 years); SMT (selective mass
treatment, treatment of both active cases and direct contacts).
doi:10.1371/journal.pone.0006338.t002
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yaws
Among the 383 persons with cutaneous lesions clinically
suggestive of yaws, 37.6% (144/383) were less than 15 years of
age (Table 1). Twenty-six individuals (6.8%) displayed lesions
suggestive of primary cutaneous yaws, 310 (80.9%) had lesions
suggestive of secondary yaws and 17 (4.4%) had lesions suggestive
of tertiary cutaneous yaws. The remaining 30 persons showed
lesions suggestive of a combination of primary, secondary and
tertiary yaws stages.
Active yaws cases confirmed by RPR and TPHA testing
Fifty-six persons had concomitant RPR and TPHA positive tests
confirming active yaws. Detailed information was obtained for 55
of them (Table 1). Among those, 40.1% (22/55) were less than 15
years of age. Three persons (5.5%) displayed primary cutaneous
yaws lesions, six (10.9%) had primary and secondary yaws lesions
and 41 (74.5%) had secondary yaws lesions. One patient displayed
pseudo-rachitic curvature of the tibias (Tibial sabre deformity) and
juxta-articular nodules and four patients displayed hyperkeratosis
on the soles, indicating the tertiary stage. Figures 3–6 show
examples of yaws lesions observed. The median self-reported
duration of primary cutaneous lesions was 1.0 year (inter-quartile
range (IQR): 0.2–1.8), of secondary lesions, 1.5 years (IQR: 0.4–
10.0) and of tertiary lesions, 6.5 years (IQR: 2.3–17.0).
Discussion
Knowledge of the prevalence of yaws is critical to plan
appropriate treatment strategies according to current WHO
recommendations. As it is well-known that the disease is clustered
and that its prevalence can vary greatly between villages, we used
the LQAS method as a rapid way of assessing the prevalence in
groups of villages instead of using classical sampling in the entire
population. The finding that some lots had a high prevalence of
over 10% while the overall prevalence was 4.7% underlines the
benefit of this strategy. If the treatment decision had been based
Figure 3. Primary ulcer lesion observed during yaws outbreak,
rural Wasolo health zone, Equator province, Democratic
Republic of the Congo, February 2005 (picture taken by
Laurent Ferradini).
doi:10.1371/journal.pone.0006338.g003
Figure 4. Papilloma secondary lesion with polydactilitis
observed during yaws outbreak, rural Wasolo health zone,
Equator province, Democratic Republic of the Congo, February
2005 (picture taken by Laurent Ferradini).
doi:10.1371/journal.pone.0006338.g004
Figure 5. Disseminated papilloma and ulcerative secondary
lesions observed during yaws outbreak, rural Wasolo health
zone, Equator province, Democratic Republic of the Congo,
February 2005 (picture taken by Sibylle Gerstl).
doi:10.1371/journal.pone.0006338.g005
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total mass treatment would not have been carried out in any of the
villages, even though some displayed high prevalence of the
disease. In addition, when considering only the overall prevalence
estimation, it would have been difficult to follow treatment
recommendations because the 95% confidence interval of 3.4 to
6.0 encompassed the critical 5% threshold level recommended by
WHO to define appropriate distinct treatment strategies.
In April 2005 following this study, MSF launched a campaign
offering free treatment to more than 16,000 people in the villages
of the rural Wasolo health zone based on the prevalence estimates
in the different groups of villages. Our study nicely illustrates the
benefit of using LQAS as an operational research method to
rapidly determine the prevalence of yaws in distinct areas in order
to define appropriate treatment strategies.
Some data and methodological limitations of our study should
be mentioned. The different study teams had varying levels of
clinical skills in diagnosing the disease. In the context of a known
yaws outbreak, clinical diagnosis may lead to an overestimation of
potential active yaws cases. Systematic serological tests of
suspected cases were performed to confirm the diagnosis and
illustrated this overestimation problem. A relatively low percent-
age of suspected cases were confirmed serologically. For instance,
lesions of the soles, which are very frequent in rural populations
not wearing shoes, where most commonly clinically overdiagnosed
as yaws but not confirmed by RPR and TPHA tests. However,
these tests have themselves well-known limitations. Indeed,
Treponema pallidum includes three subspecies of antigenically highly
related organisms, which can only be distinguished on the basis of
epidemiological characteristics and clinical manifestations, but not
by morphological, immunological and serological methods
[29,30]. Several laboratory methods of identification have been
proposed so far, but all have failed to differentiate distinct
subspecies [3,31–33]. Thus, the serological tests used in this study
could not distinguish between subspecies of Treponema pallidum and
did not allow us to confidently diagnose yaws over other
treponemal infections. However, RPR and TPHA positive tests
in persons under 15 years old are very likely to be due to yaws,
because this population is usually not yet sexually active and is very
unlikely to display syphilis infection. In our study, 40% of persons
with active yaws were under 15 years old and thus most likely
represent true active yaws cases. Overall prevalence of active yaws
cases was also slightly higher for persons under 15 years old than
for the entire study population. For persons above 15 years old
who are known to be sexually active, syphilis infection cannot be
strictly excluded. However, none of these persons had unequivocal
lesions suggestive of syphilis, making such a diagnosis unlikely in
the presence of lesions classically suggestive of yaws. Therefore, we
are confident that the serologically confirmed cases in our study
corresponded to true yaws. We are also aware of reported
examples of nonsexual transmission of syphilis via direct skin-to-
skin contact [34] and this possibility could not be excluded in the
context of our study.
Finally, we observed that only about one quarter of the RPR
positive cases were confirmed by TPHA. It is known that the RPR
test is not specific for antibodies to Treponema spp. and that some
concomitant diseases such as malaria and HIV infections may
cause false-positive tests [34,35]. Since there was no prevalence
data available for other diseases in our study area, we do not have
any satisfactory explanations for the high rate of false positives
RPR tests observed within the context of our study.
Between December 2004 and February 2005 more than 2500
cases with cutaneous lesions clinically suggestive of yaws were
reported by health personnel working in different health centres in
the rural Wasolo health zone, an isolated region in the North of
DRC (personal communication, main health office, rural health
zone Wasolo, 2005). These findings were confirmed by our survey
revealing an overall prevalence of active yaws of 4.7% (95%CI:
3.4–6.0). This prevalence estimate was similar to that reported in
the few yaws outbreaks documented in other African countries,
such as in Ghana in 1981 (4.0%) [15] and in the mid-Hawal river
valley in Nigeria in 1998 (4.2%) [36]. More than 90% of
individuals with active yaws in our study presented with the
secondary stage and consequently had long-standing contagious
lesions. The presence of these secondary stage cases could explain
the transmission and maintenance of the disease in the study area,
an assumption supported by the characteristics of a yaws outbreak
observed in Thailand [37].
Th epr e s e nc eofy a w sint h er ura lW a s o l oh e al thz on eisve ryl i ke l yto
be the consequence of a progressive increase of yaws cases in an area
where the disease was supposed to be eradicated but where new cases
had been reported in the past [18,19]. This occurred most likely
because of the steady degradation of health structures in this very
remote, rural area. Indeed, DRC is going through a dreadful civil war
and the study area in particular was heavily involved in long lasting
armed conflicts during the last few years. The distribution of endemic
treponematosis is known to be closely related to poverty and isolation
Figure 6. Sabre tibia deformity (tertiary lesions) observed
during yaws outbreak, rural Wasolo health zone, Equator
province, Democratic Republic of the Congo, February 2005
(picture taken by Laurent Ferradini).
doi:10.1371/journal.pone.0006338.g006
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consequence of poor health structures, control of yaws and other
diseases became largely inefficient. Furthermore, as in many countries,
yaws is no longer considered a health priority in the DRC, explaining
why its simple treatment is not currently available even at health
centres.However,theInternationalTaskForceforDisease Eradication
(ITFDE) reviewed the case of yaws at its eleventh meeting in October
2007 and the disease seems to be back on WHO’s agenda [29,38]. In
addition, articles in scientific journals on yaws currently raise interest
[39,40].
Among measures for potential eradication of the disease, the
implementation of a long term yaws control system with free
access to treatment is urgently needed to avoid the further spread
of this debilitating disease in the rural Wasolo health zone but also
in neighbouring health zones and districts. Horizontal pro-
grammes in which community-based health workers are involved
in all aspects of disease control have yielded very positive results in
Ecuador [41]. In Malaysia, excellent results were obtained from
the appropriate training of all health workers to recognise and
treat yaws cases [42]. In India, the goal of having zero cases was
achieved in 2006 mainly due to active case detection and
treatment of cases and contacts [43,44]. According to a study
conducted in Ghana, the most critical requirement might be the
availability and affordability of benzathine penicillin in remote
health centres [10].
In conclusion, yaws is a highly curable neglected tropical
disease. Our study showed the advantage of LQAS as a rather
uncommon sampling method to rapidly estimate the prevalence of
yaws in order to treat affected populations according to WHO
recommendations. The control of yaws should remain a public
health priority. The disability and disfigurement resulting from this
disease cause individual suffering and will also have indirect and
largely unrecorded effects on the morbidity and mortality of
affected populations.
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